Wolverine Stack Protocol
Overview
The Wolverine Stack is the gold-standard peptide protocol for accelerating healing of musculoskeletal injuries — tendons, ligaments, muscle tears, and bone. Named for its aggressive regenerative approach, it combines the complementary mechanisms of BPC-157 (local angiogenesis and fibroblast activation) with TB-500 (systemic actin upregulation and cell migration). Together they achieve faster, more complete tissue repair than either alone. Expected outcomes include significantly reduced recovery time, reduced pain, improved range of motion, and superior tissue quality compared to rest alone.
Components
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| BPC-157 | 250-500 mcg | Daily | 4-12 weeks |
| TB-500 | 2.5 mg | 2x/week (loading phase, weeks 1-4) | 4 weeks |
| TB-500 | 2.5 mg | Once weekly (maintenance) | 4-8 weeks |
Optional additions:
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| GHK-Cu | Topical or 1-2 mg SubQ | Daily topical / 2x week injectable | Throughout |
| PEG-MGF | 200-400 mcg | 2-3x/week | 4-6 weeks |
Administration
- BPC-157: SubQ injection near injury site preferred (peri-lesional) or systemically; alternatively oral capsule 500mcg for gut-related injuries. Inject with insulin syringe, pinched skin, 45-degree angle. Saline reconstitution.
- TB-500: SubQ injection, any site (systemic distribution makes location less critical). Abdominal or thigh preferred for convenience.
- Timing: BPC-157 can be taken any time of day. TB-500 timing is flexible — morning preferred.
- Fasting: Not required for either peptide.
Cycling
- Loading phase: Weeks 1-4 — TB-500 2x/week + daily BPC-157
- Maintenance phase: Weeks 5-12 — TB-500 weekly + daily BPC-157
- Post-protocol: 4-8 weeks off before repeating if needed
- For chronic or severe injuries, extended protocols up to 16 weeks may be appropriate with clinical guidance
Expected Timeline
- Week 1-2: Reduced inflammation and pain at injury site; improved mobility beginning
- Week 3-4: Noticeable functional improvement; tissue repair measurable on imaging in some cases
- Week 5-8: Significant strength and stability restoration; continued remodeling
- Week 9-12: Near-complete or complete functional recovery for most musculoskeletal injuries
Monitoring
- Track pain scores and range of motion weekly
- Ultrasound or MRI at 6-8 weeks to objectively assess structural repair
- Watch for injection site reactions (redness, swelling) — usually transient
- BPC-157 may temporarily lower blood pressure; monitor if on antihypertensives
Contraindications
- Active cancer or history of cancer (growth-promoting mechanisms are contraindicated)
- Pregnancy or breastfeeding
- Known hypersensitivity to peptide components
- Individuals with severe coagulation disorders should consult physician before injectable use
Sources
#protocol #injury #recovery #wolverine #BPC157 #TB500 #musculoskeletal